Chemomab Therapeutics Ltd. (CMMB) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chemomab Therapeutics Ltd...

    NASDAQ: CMMB · Real-Time Price · USD
    2.72
    0.02 (0.74%)
    At close: Oct 03, 2025, 3:59 PM
    2.71
    -0.37%
    After-hours: Oct 03, 2025, 04:37 PM EDT

    Chemomab Therapeutics Revenue

    Chemomab Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Chemomab Therapeutics generated $0 in revenue.
    Revenue (ttm)
    0
    Revenue Growth
    n/a
    Price / Sales Ratio
    0
    Revenue / Employee
    0
    Employees
    20
    Market Cap
    3.15M

    Revenue Chart

    History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 0 n/a
    Dec 31, 2023 0 n/a
    Dec 31, 2022 0 n/a
    Dec 31, 2021 0 n/a
    Dec 31, 2020 0 n/a
    Dec 31, 2019 0 n/a
    Dec 31, 2018 0 n/a
    Dec 31, 2017 0 n/a
    Dec 31, 2016 0 n/a
    Dec 31, 2015 0 n/a
    Dec 31, 2014 0 n/a
    Dec 31, 2013 0 n/a
    Dec 31, 2012 0 n/a
    Dec 31, 2011 0 n/a
    Dec 31, 2010 0 n/a
    Dec 31, 2009 0 n/a
    Dec 31, 2008 0 n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist